A review of latest clinical practice guidelines for the management of cancer-associated thrombosis (2022)
- Authors:
- Autor USP: PRATA, PEDRO HENRIQUE DE LIMA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.beha.2022.101348
- Subjects: TROMBOSE; NEOPLASIAS; PRÁTICA CLÍNICA; REVISÃO SISTEMÁTICA
- Keywords: Venous thromboembolism; Cancer; Guidelines; Prevention; Treatment
- Language: Inglês
- Imprenta:
- Source:
- Título: Best Practice & Research: Clinical Haematology
- ISSN: 1521-6926
- Volume/Número/Paginação/Ano: v. 35, art. 101348, p. 1-20, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRERE, Corinne et al. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, v. 35, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.beha.2022.101348. Acesso em: 21 jan. 2026. -
APA
Frere, C., Wahl, C., Rueda-Camino, J. A., Crichi, B., Prata, P. H. de L., Marjanovic, Z., & Farge, D. (2022). A review of latest clinical practice guidelines for the management of cancer-associated thrombosis. Best Practice & Research: Clinical Haematology, 35, 1-20. doi:10.1016/j.beha.2022.101348 -
NLM
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1016/j.beha.2022.101348 -
Vancouver
Frere C, Wahl C, Rueda-Camino JA, Crichi B, Prata PH de L, Marjanovic Z, Farge D. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [Internet]. Best Practice & Research: Clinical Haematology. 2022 ; 35 1-20.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1016/j.beha.2022.101348 - Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials
- Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study
- IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]
- Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria
- Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria
Informações sobre o DOI: 10.1016/j.beha.2022.101348 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003268069.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
